Literature DB >> 21184256

Tissue procurement strategies affect the protein biochemistry of human heart samples.

Lori A Walker1, Allen M Medway, John S Walker, Joseph C Cleveland, Peter M Buttrick.   

Abstract

The ability to analyze the biochemical properties of human cardiac tissue is critical both to an understanding of cardiac pathology and also to the development of novel pharmacotherapies. However current strategies for tissue procurement are not uniform and are potentially biased. In this study we contrasted several commonly used approaches for tissue sampling in order to determine their impact on contractile protein biochemistry. Not surprisingly our results show that different tissue handling strategies have the potential to produce a wide variation in the phosphorylation and proteolysis of selected contractile proteins. However this was not uniform: phosphorylation of troponin I (TnI) and myosin light chain 2 (MLC2) varied significantly depending on approach whereas changes in desmin and myosin binding protein C (MyBP-C) were relatively unaffected. Moreover, some strategies increased whereas others reduced TnI phosphorylation, suggesting a dynamic balance between kinase and phosphatase activities. Overall, procurement strategies that involved maintenance of tissue in cardioplegia solution deviated most dramatically from prompt and rapid tissue immersion in liquid nitrogen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184256     DOI: 10.1007/s10974-010-9233-6

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  30 in total

1.  Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts-- evidence for novel phosphorylation sites.

Authors:  Chao Yuan; Yurong Guo; Rajashree Ravi; Karin Przyklenk; Nicole Shilkofski; Roberto Diez; Robert N Cole; Anne M Murphy
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

2.  Why does troponin I have so many phosphorylation sites? Fact and fancy.

Authors:  R John Solaro; Jolanda van der Velden
Journal:  J Mol Cell Cardiol       Date:  2010-02-25       Impact factor: 5.000

3.  Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle.

Authors:  O'Neal Copeland; Sakthivel Sadayappan; Andrew E Messer; Ger J M Steinen; Jolanda van der Velden; Steven B Marston
Journal:  J Mol Cell Cardiol       Date:  2010-09-17       Impact factor: 5.000

4.  Myocardial structure and function differ in systolic and diastolic heart failure.

Authors:  Loek van Heerebeek; Attila Borbély; Hans W M Niessen; Jean G F Bronzwaer; Jolanda van der Velden; Ger J M Stienen; Wolfgang A Linke; Gerrit J Laarman; Walter J Paulus
Journal:  Circulation       Date:  2006-04-17       Impact factor: 29.690

5.  Cardiac myosin binding protein C phosphorylation is cardioprotective.

Authors:  Sakthivel Sadayappan; Hanna Osinska; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffrey D Molkentin; Christine E Seidman; Jonathan G Seidman; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

6.  Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.

Authors:  Adam M Jacques; O'Neal Copeland; Andrew E Messer; Clare E Gallon; Katie King; William J McKenna; Victor T Tsang; Steven B Marston
Journal:  J Mol Cell Cardiol       Date:  2008-06-04       Impact factor: 5.000

7.  In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated.

Authors:  Serife Ayaz-Guner; Jiang Zhang; Lin Li; Jeffery W Walker; Ying Ge
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

8.  Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure.

Authors:  Rashad J Belin; Marius P Sumandea; Edward J Allen; Kelly Schoenfelt; Helen Wang; R John Solaro; Pieter P de Tombe
Journal:  Circ Res       Date:  2007-06-07       Impact factor: 17.367

9.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

10.  Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution.

Authors:  Xiaoke Yin; Friederike Cuello; Ursula Mayr; Zhiqi Hao; Martin Hornshaw; Elisabeth Ehler; Metin Avkiran; Manuel Mayr
Journal:  Mol Cell Proteomics       Date:  2009-12-27       Impact factor: 5.911

View more
  18 in total

Review 1.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

2.  Distinct sequences and post-translational modifications in cardiac atrial and ventricular myosin light chains revealed by top-down mass spectrometry.

Authors:  Zachery R Gregorich; Wenxuan Cai; Ziqing Lin; Albert J Chen; Ying Peng; Takushi Kohmoto; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2017-04-17       Impact factor: 5.000

3.  Myofilament dysfunction contributes to impaired myocardial contraction in the infarct border zone.

Authors:  Rafael Shimkunas; Om Makwana; Kimberly Spaulding; Mona Bazargan; Michael Khazalpour; Kiyoaki Takaba; Mehrdad Soleimani; Bat-Erdene Myagmar; David H Lovett; Paul C Simpson; Mark B Ratcliffe; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

4.  Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support.

Authors:  Amrut V Ambardekar; John S Walker; Lori A Walker; Joseph C Cleveland; Brian D Lowes; Peter M Buttrick
Journal:  Circ Heart Fail       Date:  2011-05-03       Impact factor: 8.790

5.  Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Authors:  Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

Review 6.  The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings.

Authors:  Maryam Shabihkhani; Gregory M Lucey; Bowen Wei; Sergey Mareninov; Jerry J Lou; Harry V Vinters; Elyse J Singer; Timothy F Cloughesy; William H Yong
Journal:  Clin Biochem       Date:  2014-01-12       Impact factor: 3.281

7.  Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes.

Authors:  Peter A Galie; Nashmia Khalid; Kelly E Carnahan; Margaret V Westfall; Jan P Stegemann
Journal:  Cardiovasc Pathol       Date:  2012-12-21       Impact factor: 2.185

8.  Contractile protein phosphorylation predicts human heart disease phenotypes.

Authors:  Lori A Walker; David A Fullerton; Peter M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-05       Impact factor: 4.733

9.  Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy.

Authors:  Stephanie J Nakano; John S Walker; Lori A Walker; Xiaotao Li; Yanmei Du; Shelley D Miyamoto; Carmen C Sucharov; Anastacia M Garcia; Max B Mitchell; Amrut V Ambardekar; Brian L Stauffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-18       Impact factor: 4.733

10.  Temperature-sensitive sarcomeric protein post-translational modifications revealed by top-down proteomics.

Authors:  Wenxuan Cai; Zachary L Hite; Beini Lyu; Zhijie Wu; Ziqing Lin; Zachery R Gregorich; Andrew E Messer; Sean J McIlwain; Steve B Marston; Takushi Kohmoto; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2018-07-23       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.